171 related articles for article (PubMed ID: 10534250)
1. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD.
Ulivelli M; Rossi S; Pasqualetti P; Rossini PM; Ghiglieri O; Passero S; Battistini N
Neurology; 1999 Oct; 53(7):1451-7. PubMed ID: 10534250
[TBL] [Abstract][Full Text] [Related]
2. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.
Cheron G; Piette T; Thiriaux A; Jacquy J; Godaux E
Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767
[TBL] [Abstract][Full Text] [Related]
3. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism.
Rossini PM; Bassetti MA; Pasqualetti P
Electroencephalogr Clin Neurophysiol; 1995 May; 96(3):236-47. PubMed ID: 7750449
[TBL] [Abstract][Full Text] [Related]
4. [Somatosensory evoked potentials and symptomatic response to dopaminergic drugs in Parkinson's disease].
Castillo JL; Miranda CM; Araya F; Sáez D
Rev Med Chil; 1996 Mar; 124(3):301-6. PubMed ID: 9008941
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiology of sensorimotor integration in Parkinson's disease.
Rossini PM; Filippi MM; Vernieri F
Clin Neurosci; 1998; 5(2):121-30. PubMed ID: 10785838
[TBL] [Abstract][Full Text] [Related]
6. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
de Mari M; Margari L; Lamberti P; Iliceto G; Ferrari E
J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.
Mauguière F; Broussolle E; Isnard J
Electroencephalogr Clin Neurophysiol; 1993; 88(4):243-54. PubMed ID: 7688279
[TBL] [Abstract][Full Text] [Related]
8. [Frontal SEPs and parietal SEPs following median nerve stimulation--clinical correlation and consideration of their generation sites].
Urasaki E; Matukado Y; Wada S; Nagahiro S; Yamaguchi T; Yadomi C
No To Shinkei; 1986 Oct; 38(10):973-80. PubMed ID: 3790362
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components.
Rossini PM; Traversa R; Boccasena P; Martino G; Passarelli F; Pacifici L; Bernardi G; Stanzione P
Neurology; 1993 Dec; 43(12):2495-500. PubMed ID: 8255446
[TBL] [Abstract][Full Text] [Related]
10. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients.
Pierantozzi M; Mazzone P; Bassi A; Rossini PM; Peppe A; Altibrandi MG; Stefani A; Bernardi G; Stanzione P
Clin Neurophysiol; 1999 Oct; 110(10):1700-7. PubMed ID: 10574285
[TBL] [Abstract][Full Text] [Related]
11. Brain excitability and long latency muscular arm responses: non-invasive evaluation in healthy and parkinsonian subjects.
Rossini PM; Paradiso C; Zarola F; Bernardi G; Caramia MD; Margari L; Ferrari E
Electroencephalogr Clin Neurophysiol; 1991 Dec; 81(6):454-65. PubMed ID: 1721587
[TBL] [Abstract][Full Text] [Related]
12. Somatosensory, motor and special visual evoked potentials to single and double stimulation in "Parkinson's disease" an early diagnostic test?
Jörg J; Gerhard H
J Neural Transm Suppl; 1987; 25():81-8. PubMed ID: 3480940
[TBL] [Abstract][Full Text] [Related]
13. N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease.
Drory VE; Inzelberg R; Groozman GB; Korczyn AD
Acta Neurol Scand; 1998 Feb; 97(2):73-6. PubMed ID: 9517855
[TBL] [Abstract][Full Text] [Related]
14. Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach.
Bostantjopoulou S; Katsarou Z; Zafiriou D; Gerasimou G; Alevriadou A; Georgiadis G; Kiosseoglou G; Kazis A
Neurophysiol Clin; 2000 Dec; 30(6):368-76. PubMed ID: 11191929
[TBL] [Abstract][Full Text] [Related]
15. Abnormal central integration of a dual somatosensory input in dystonia. Evidence for sensory overflow.
Tinazzi M; Priori A; Bertolasi L; Frasson E; Mauguière F; Fiaschi A
Brain; 2000 Jan; 123 ( Pt 1)():42-50. PubMed ID: 10611119
[TBL] [Abstract][Full Text] [Related]
16. Effects of stimulus intensity on frontal, central and parietal somatosensory evoked potentials after median nerve stimulation.
Huttunen J
Electromyogr Clin Neurophysiol; 1995; 35(4):217-23. PubMed ID: 7555926
[TBL] [Abstract][Full Text] [Related]
17. Absence of frontal somatosensory evoked potentials in Huntington's disease.
Töpper R; Schwarz M; Podoll K; Dömges F; Noth J
Brain; 1993 Feb; 116 ( Pt 1)():87-101. PubMed ID: 8453467
[TBL] [Abstract][Full Text] [Related]
18. Recovery functions of somatosensory evoked potentials in parkinsonian patients.
Nakashima K; Nitta T; Takahashi K
J Neurol Sci; 1992 Mar; 108(1):24-31. PubMed ID: 1624948
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients.
Rossini PM; Babiloni F; Bernardi G; Cecchi L; Johnson PB; Malentacca A; Stanzione P; Urbano A
Electroencephalogr Clin Neurophysiol; 1989; 74(4):277-89. PubMed ID: 2471629
[TBL] [Abstract][Full Text] [Related]
20. The Effect of L-Dopa/Carbidopa Intestinal Gel in Parkinson Disease Assessed Using Neurophysiologic Techniques.
Bologna M; Latorre A; Di Biasio F; Conte A; Belvisi D; Modugno N; Suppa A; Berardelli A; Fabbrini G
Clin Neuropharmacol; 2016; 39(6):302-305. PubMed ID: 27755134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
